Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.biomaterials.2013.09.036
Title: Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
Authors: Yoong, S.L.
Wong, B.S.
Zhou, Q.L.
Chin, C.F.
Li, J. 
Venkatesan, T. 
Ho, H.K. 
Yu, V.
Ang, W.H. 
Pastorin, G. 
Keywords: 3-Bromopyruvate
Cisplatin
Mitochondria
Multi-walled carbon nanotubes
Platinum(IV) prodrug
Rhodamine
Issue Date: Jan-2014
Source: Yoong, S.L., Wong, B.S., Zhou, Q.L., Chin, C.F., Li, J., Venkatesan, T., Ho, H.K., Yu, V., Ang, W.H., Pastorin, G. (2014-01). Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin. Biomaterials 35 (2) : 748-759. ScholarBank@NUS Repository. https://doi.org/10.1016/j.biomaterials.2013.09.036
Abstract: Among the arsenal of nano-materials, carbon nanotubes (CNTs) are becoming more prominent due to favorable attributes including their unique shape, which promotes cellular-uptake, and large aspect-ratio that facilitates functionalization of bioactive molecules on their surface. In this study, multi-walled carbon nanotubes (MWCNTs) were functionalized with either mitochondrial-targeting fluorescent rhodamine-110 (MWCNT-Rho) or non-targeting fluorescein (MWCNT-Fluo). Despite structural similarities, MWCNT-Rho associated well with mitochondria (ca. 80% co-localization) in contrast to MWCNT-Fluo, which was poorly localized (ca. 21% co-localization). Additionally, MWCNT-Rho entrapping platinum(IV) pro-drug of cisplatin (PtBz) displayed enhanced potency (IC50=0.34±0.07μM) compared to a construct based on MWCNT-Fluo (IC50≥2.64μM). Concurrently, preliminary invitro toxicity evaluation revealed that empty MWCNT-Rho neither decreased cell viability significantly nor interfered with mitochondrial membrane-potential, while seemingly being partially expelled from cells. Due to its targeting capability and apparent lack of cytotoxicity, MWCNT-Rho complex was used to co-encapsulate PtBz and a chemo-potentiator, 3-bromopyruvate (BP), and the resulting MWCNT-Rho(PtBz+BP) construct demonstrated superior efficacy over PtBz free drug in several cancer cell lines tested. Importantly, a 2-fold decrease in mitochondrial potential was observed, implying that mitochondrial targeting of compounds indeed incurred additional intended damage to mitochondria. © 2013 Elsevier Ltd.
Source Title: Biomaterials
URI: http://scholarbank.nus.edu.sg/handle/10635/55882
ISSN: 01429612
DOI: 10.1016/j.biomaterials.2013.09.036
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

45
checked on Dec 5, 2017

WEB OF SCIENCETM
Citations

41
checked on Nov 13, 2017

Page view(s)

72
checked on Dec 9, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.